Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Anthony T,Corcoran

第一单位： Department of Urology, SUNY Stony Brook Medical Center, Stony Brook, NY, USA.

作者： Anthony T,Corcoran ^[1] ; Samuel D,Kaffenberger ^[2] ; Peter E,Clark ^[2] ; John,Walton ^[3] ; Elizabeth,Handorf ^[4] ; Zack,Piotrowski ^[3] ; Jeffery J,Tomaszewski ^[3] ; Serge,Ginzburg ^[5] ; Reza,Mehrazin ^[3] ; Elizabeth,Plimack ^[6] ; David Y T,Chen ^[3] ; Marc C,Smaldone ^[3] ; Robert G,Uzzo ^[3] ; Todd M,Morgan ^[7] ; Alexander,Kutikov ^[3]

作者单位： Department of Urology, SUNY Stony Brook Medical Center, Stony Brook, NY, USA. ^[1] Department of Urology, Vanderbilt University School of Medicine, Nashville, TN, USA. ^[2] Division of Urologic Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA. ^[3] Biostatistics & Bioinformatics Facility, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA. ^[4] Department of Urology, Einstein Healthcare Network/Urologic Institute of Southeastern Pennsylvania, Philadelphia, PA, USA. ^[5] Medical Oncology, Fox Chase Cancer Center-Temple University Health System, Philadelphia, PA, USA. ^[6] Department of Urology, University of Michigan School of Medicine, Ann Arbor, MI, USA. ^[7]

关键词 cytoreductive nephrectomy metastatic renal cell carcinoma nutritional status survival systemic therapy